{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:04:40Z","timestamp":1781327080101,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TC108A02-6"],"award-info":[{"award-number":["KMU-TC108A02-6"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Low transferrin saturation (TSAT), calculated by serum iron divided by total iron-binding capacity (TIBC), indicates iron deficiency. Because malnutrition and inflammation are associated with low TIBC in chronic kidney disease (CKD), TSAT might not reflect iron status or risk for anemia. We examined whether low serum iron was a risk factor for anemia in CKD patients with normal TSAT. Thus we compare the risk for anemia in 2500 CKD stage 1\u20134 patients divided by TSAT (cutoff: 20%) and serum iron (cutoff: 70\u00a0\u03bcg\/dL in men, 60\u00a0\u03bcg\/dL in women). Our results confirmed low TIBC (&lt;\u2009200\u00a0\u03bcg\/dL) was associated with hypoalbuminemia and high C-reactive protein. In fully-adjusted logistic regression, both \u201cnormal TSAT low iron\u201d and \u201clow TSAT low iron\u201d groups were associated with baseline anemia (hemoglobin\u2009&lt;\u200911\u00a0g\/dL) (odds ratios (OR) 1.56; 95% confidence interval (CI) 1.13\u20132.16 and OR 2.36; 95% CI 1.76\u20133.18, respectively) compared with the reference group (normal TSAT normal iron). Sensitivity tests with different cutoffs for TSAT and iron also showed similar results. In patients without anemia, both groups were associated with anemia after 1\u00a0year (OR 1.69; 95% CI 1.00\u20132.83 and OR 1.94; 95% CI 1.11\u20133.40, respectively). In conclusion, CKD stage 1\u20134 patients with normal TSAT but low serum iron are still at risk for anemia.<\/jats:p>","DOI":"10.1038\/s41598-021-87401-w","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T11:36:09Z","timestamp":1618572969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Low serum iron is associated with anemia in CKD stage 1\u20134 patients with normal transferrin saturations"],"prefix":"10.1038","volume":"11","author":[{"given":"Pei-Hua","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Jyh","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chih","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"87401_CR1","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2011111078","volume":"23","author":"JL Babitt","year":"2012","unstructured":"Babitt, J. L. & Lin, H. Y. Mechanisms of anemia in CKD. J. Am. Soc. Nephrol. 23, 1631\u20131634. https:\/\/doi.org\/10.1681\/ASN.2011111078 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"87401_CR2","volume-title":"Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity (WHO, 2011)."},{"key":"87401_CR3","doi-asserted-by":"publisher","first-page":"e84943","DOI":"10.1371\/journal.pone.0084943","volume":"9","author":"ME Stauffer","year":"2014","unstructured":"Stauffer, M. E. & Fan, T. Prevalence of anemia in chronic kidney disease in the United States. PLoS ONE 9, e84943. https:\/\/doi.org\/10.1371\/journal.pone.0084943 (2014).","journal-title":"PLoS ONE"},{"key":"87401_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3346\/jkms.2017.32.2.249","volume":"32","author":"SR Ryu","year":"2017","unstructured":"Ryu, S. R. et al. The Prevalence and management of anemia in chronic kidney disease patients: Result from the Korean cohort study for outcomes in patients with chronic kidney disease (KNOW-CKD). J. Korean Med. Sci. 32, 249\u2013256. https:\/\/doi.org\/10.3346\/jkms.2017.32.2.249 (2017).","journal-title":"J. Korean Med. Sci."},{"key":"87401_CR5","doi-asserted-by":"publisher","first-page":"e3872","DOI":"10.1097\/MD.0000000000003872","volume":"95","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: First multicenter, cross-sectional study. Medicine (Baltimore) 95, e3872. https:\/\/doi.org\/10.1097\/MD.0000000000003872 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"87401_CR6","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/s0735-1097(02)01854-5","volume":"39","author":"TB Horwich","year":"2002","unstructured":"Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R. & Borenstein, J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J. Am. Coll. Cardiol. 39, 1780\u20131786. https:\/\/doi.org\/10.1016\/s0735-1097(02)01854-5 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"87401_CR7","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1182\/blood-2005-10-4308","volume":"107","author":"BF Culleton","year":"2006","unstructured":"Culleton, B. F. et al. Impact of anemia on hospitalization and mortality in older adults. Blood 107, 3841\u20133846. https:\/\/doi.org\/10.1182\/blood-2005-10-4308 (2006).","journal-title":"Blood"},{"key":"87401_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s10157-017-1468-8","volume":"22","author":"Y Sato","year":"2018","unstructured":"Sato, Y. et al. Anemia as a risk factor for all-cause mortality: Obscure synergic effect of chronic kidney disease. Clin. Exp. Nephrol. 22, 388\u2013394. https:\/\/doi.org\/10.1007\/s10157-017-1468-8 (2018).","journal-title":"Clin. Exp. Nephrol."},{"key":"87401_CR9","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s12325-017-0566-z","volume":"34","author":"A Covic","year":"2017","unstructured":"Covic, A., Jackson, J., Hadfield, A., Pike, J. & Siriopol, D. Real-world impact of cardiovascular disease and anemia on quality of life and productivity in patients with non-dialysis-dependent chronic kidney disease. Adv. Ther. 34, 1662\u20131672. https:\/\/doi.org\/10.1007\/s12325-017-0566-z (2017).","journal-title":"Adv. Ther."},{"key":"87401_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.7326\/0003-4819-153-1-201007060-00252","volume":"153","author":"SC Palmer","year":"2010","unstructured":"Palmer, S. C. et al. Meta-analysis: Erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann. Intern. Med. 153, 23\u201333. https:\/\/doi.org\/10.7326\/0003-4819-153-1-201007060-00252 (2010).","journal-title":"Ann. Intern. Med."},{"key":"87401_CR11","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1158\/1078-0432.CCR-10-2577","volume":"17","author":"BD Hedley","year":"2011","unstructured":"Hedley, B. D., Allan, A. L. & Xenocostas, A. The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression. Clin. Cancer Res. 17, 6373\u20136380. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-2577 (2011).","journal-title":"Clin. Cancer Res."},{"key":"87401_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000496492","volume":"142","author":"A Gafter-Gvili","year":"2019","unstructured":"Gafter-Gvili, A., Schechter, A. & Rozen-Zvi, B. Iron deficiency anemia in chronic kidney disease. Acta Haematol. 142, 44\u201350. https:\/\/doi.org\/10.1159\/000496492 (2019).","journal-title":"Acta Haematol."},{"key":"87401_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","volume":"89","author":"IC Macdougall","year":"2016","unstructured":"Macdougall, I. C. et al. Iron management in chronic kidney disease: Conclusions from a \u201cKidney Disease: Improving global outcomes\u201d (KDIGO) controversies conference. Kidney Int. 89, 28\u201339. https:\/\/doi.org\/10.1016\/j.kint.2015.10.002 (2016).","journal-title":"Kidney Int."},{"key":"87401_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2215\/CJN.04280609","volume":"5","author":"S Stancu","year":"2010","unstructured":"Stancu, S., Barsan, L., Stanciu, A. & Mircescu, G. Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?. Clin. J. Am. Soc. Nephrol. 5, 409\u2013416. https:\/\/doi.org\/10.2215\/CJN.04280609 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"87401_CR15","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1681\/ASN.V7122654","volume":"7","author":"S Fishbane","year":"1996","unstructured":"Fishbane, S., Kowalski, E. A., Imbriano, L. J. & Maesaka, J. K. The evaluation of iron status in hemodialysis patients. J. Am. Soc. Nephrol. 7, 2654\u20132657 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"key":"87401_CR16","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2006.03.010","volume":"47","author":"National Kidney Foundation","year":"2006","unstructured":"National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am. J. Kidney Dis. 47, S1\u2013S146. https:\/\/doi.org\/10.1053\/j.ajkd.2006.03.010 (2006).","journal-title":"Am. J. Kidney Dis."},{"key":"87401_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/kisup.2012.37","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int. Suppl. 2, 279\u2013335 (2012).","journal-title":"Kidney Int. Suppl."},{"key":"87401_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/0272-6386(95)90649-5","volume":"26","author":"K Kalantar-Zadeh","year":"1995","unstructured":"Kalantar-Zadeh, K. et al. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am. J. Kidney Dis. 26, 292\u2013299. https:\/\/doi.org\/10.1016\/0272-6386(95)90649-5 (1995).","journal-title":"Am. J. Kidney Dis."},{"key":"87401_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000191470","volume":"29","author":"R Bross","year":"2009","unstructured":"Bross, R. et al. Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients. Am. J. Nephrol. 29, 571\u2013581. https:\/\/doi.org\/10.1159\/000191470 (2009).","journal-title":"Am. J. Nephrol."},{"key":"87401_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/0090-1229(84)90076-x","volume":"33","author":"BL Warshaw","year":"1984","unstructured":"Warshaw, B. L., Check, I. J., Hymes, L. C. & DiRusso, S. C. Decreased serum transferrin concentration in children with the nephrotic syndrome: Effect on lymphocyte proliferation and correlation with serum immunoglobulin levels. Clin. Immunol. Immunopathol. 33, 210\u2013219. https:\/\/doi.org\/10.1016\/0090-1229(84)90076-x (1984).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"87401_CR21","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1093\/ndt\/gfh454","volume":"19","author":"AJ Branten","year":"2004","unstructured":"Branten, A. J., Swinkels, D. W., Klasen, I. S. & Wetzels, J. F. Serum ferritin levels are increased in patients with glomerular diseases and proteinuria. Nephrol. Dial. Transplant 19, 2754\u20132760. https:\/\/doi.org\/10.1093\/ndt\/gfh454 (2004).","journal-title":"Nephrol. Dial. Transplant"},{"key":"87401_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011866","author":"JL Miller","year":"2013","unstructured":"Miller, J. L. Iron deficiency anemia: A common and curable disease. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a011866 (2013).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"87401_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa048","author":"A Besarab","year":"2020","unstructured":"Besarab, A. & Drueke, T. B. The problem with transferrin saturation as an indicator of iron \u201csufficiency\u201d in chronic kidney disease. Nephrol. Dial. Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfaa048 (2020).","journal-title":"Nephrol. Dial. Transplant."},{"key":"87401_CR24","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation. National Kidney Foundation: K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 39, S1\u2013S266 (2002).","journal-title":"Am. J. Kidney Dis."},{"key":"87401_CR25","unstructured":"Administration, H. P. The Definition of the Metabolic Syndrome in Adults (2007). https:\/\/www.hpa.gov.tw\/Pages\/Detail.aspx?nodeid=639&pid=1219. Accessed 01 May 2007."},{"key":"87401_CR26","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1053\/ajkd.2001.29222","volume":"38","author":"K Kalantar-Zadeh","year":"2001","unstructured":"Kalantar-Zadeh, K., Kopple, J. D., Block, G. & Humphreys, M. H. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am. J. Kidney Dis. 38, 1251\u20131263. https:\/\/doi.org\/10.1053\/ajkd.2001.29222 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"87401_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.kint.2019.10.021","volume":"97","author":"HP Chiang","year":"2020","unstructured":"Chiang, H. P. et al. Blood pressure modifies outcomes in patients with stage 3 to 5 chronic kidney disease. Kidney Int. 97, 402\u2013413. https:\/\/doi.org\/10.1016\/j.kint.2019.10.021 (2020).","journal-title":"Kidney Int."},{"key":"87401_CR28","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","volume":"361","author":"MA Pfeffer","year":"2009","unstructured":"Pfeffer, M. A. et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N. Engl. J. Med. 361, 2019\u20132032. https:\/\/doi.org\/10.1056\/NEJMoa0907845 (2009).","journal-title":"N. Engl. J. Med."},{"key":"87401_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/j.ajkd.2018.11.006","volume":"73","author":"S Fishbane","year":"2019","unstructured":"Fishbane, S., Ross, D. W. & Hong, S. Anemia in non-dialysis-dependent CKD: To treat or not to treat?. Am. J. Kidney Dis. 73, 297\u2013299. https:\/\/doi.org\/10.1053\/j.ajkd.2018.11.006 (2019).","journal-title":"Am. J. Kidney Dis."},{"key":"87401_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1542-4758.2007.00175.x","volume":"11","author":"RC Kopelman","year":"2007","unstructured":"Kopelman, R. C., Smith, L., Peoples, L., Biesecker, R. & Rizkala, A. R. Functional iron deficiency in hemodialysis patients with high ferritin. Hemodial. Int. 11, 238\u2013246. https:\/\/doi.org\/10.1111\/j.1542-4758.2007.00175.x (2007).","journal-title":"Hemodial. Int."},{"key":"87401_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/s0140-6736(15)60865-0","volume":"387","author":"A Lopez","year":"2016","unstructured":"Lopez, A., Cacoub, P., Macdougall, I. C. & Peyrin-Biroulet, L. Iron deficiency anaemia. The Lancet 387, 907\u2013916. https:\/\/doi.org\/10.1016\/s0140-6736(15)60865-0 (2016).","journal-title":"The Lancet"},{"issue":"Suppl 1","key":"87401_CR32","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2215\/CJN.01490506","volume":"1","author":"JB Wish","year":"2006","unstructured":"Wish, J. B. Assessing iron status: Beyond serum ferritin and transferrin saturation. Clin. J. Am. Soc. Nephrol. 1(Suppl 1), S4\u2013S8. https:\/\/doi.org\/10.2215\/CJN.01490506 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"87401_CR33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/s0272-6386(97)90104-9","volume":"30","author":"N Mittman","year":"1997","unstructured":"Mittman, N. et al. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am. J. Kidney Dis. 30, 912\u2013922. https:\/\/doi.org\/10.1016\/s0272-6386(97)90104-9 (1997).","journal-title":"Am. J. Kidney Dis."},{"key":"87401_CR34","doi-asserted-by":"publisher","first-page":"e0204899","DOI":"10.1371\/journal.pone.0204899","volume":"13","author":"AM Nalado","year":"2018","unstructured":"Nalado, A. M. et al. Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa. PLoS ONE 13, e0204899. https:\/\/doi.org\/10.1371\/journal.pone.0204899 (2018).","journal-title":"PLoS ONE"},{"key":"87401_CR35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/s0272-6386(99)70079-x","volume":"34","author":"AM Fernandez-Rodriguez","year":"1999","unstructured":"Fernandez-Rodriguez, A. M. et al. Diagnosis of iron deficiency in chronic renal failure. Am. J. Kidney Dis. 34, 508\u2013513. https:\/\/doi.org\/10.1016\/s0272-6386(99)70079-x (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"87401_CR36","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1111\/hdi.12556","volume":"21","author":"AE Gaweda","year":"2017","unstructured":"Gaweda, A. E. Markers of iron status in chronic kidney disease. Hemodial. Int. 21, S21\u2013S27. https:\/\/doi.org\/10.1111\/hdi.12556 (2017).","journal-title":"Hemodial. Int."},{"key":"87401_CR37","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1182\/blood-2010-05-286260","volume":"116","author":"LT Goodnough","year":"2010","unstructured":"Goodnough, L. T., Nemeth, E. & Ganz, T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 116, 4754\u20134761. https:\/\/doi.org\/10.1182\/blood-2010-05-286260 (2010).","journal-title":"Blood"},{"key":"87401_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5414\/cnp58363","volume":"58","author":"WC Chiang","year":"2002","unstructured":"Chiang, W. C., Tsai, T. J., Chen, Y. M., Lin, S. L. & Hsieh, B. S. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients. Clin. Nephrol. 58, 363\u2013369. https:\/\/doi.org\/10.5414\/cnp58363 (2002).","journal-title":"Clin. Nephrol."},{"key":"87401_CR39","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/ajh.22108","volume":"86","author":"BS Skikne","year":"2011","unstructured":"Skikne, B. S. et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: A prospective multicenter evaluation of soluble transferrin receptor and the sTfR\/log ferritin index. Am. J. Hematol. 86, 923\u2013927. https:\/\/doi.org\/10.1002\/ajh.22108 (2011).","journal-title":"Am. J. Hematol."},{"key":"87401_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1053\/ajkd.1998.v31.pm9469497","volume":"31","author":"K Kalantar-Zadeh","year":"1998","unstructured":"Kalantar-Zadeh, K. et al. Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am. J. Kidney Dis. 31, 263\u2013272. https:\/\/doi.org\/10.1053\/ajkd.1998.v31.pm9469497 (1998).","journal-title":"Am. J. Kidney Dis."},{"key":"87401_CR41","doi-asserted-by":"publisher","first-page":"e0126668","DOI":"10.1371\/journal.pone.0126668","volume":"10","author":"JC Huang","year":"2015","unstructured":"Huang, J. C. et al. Body mass index, mortality, and gender difference in advanced chronic kidney disease. PLoS ONE 10, e0126668. https:\/\/doi.org\/10.1371\/journal.pone.0126668 (2015).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87401-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87401-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87401-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T06:46:46Z","timestamp":1670050006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87401-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["87401"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-87401-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"assertion":[{"value":"24 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8343"}}